Log in to save to my catalogue

The seroprevalence of adenoviruses since 2000 1

The seroprevalence of adenoviruses since 2000 1

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_40035700

The seroprevalence of adenoviruses since 2000 1

About this item

Full title

The seroprevalence of adenoviruses since 2000 1

Publisher

United States

Journal title

Emerging microbes & infections, 2025-12, Vol.14 (1), p.2475831

Language

English

Formats

Publication information

Publisher

United States

More information

Scope and Contents

Contents

Human adenoviruses (Ad) are increasingly used as vaccine vectors, especially after Ad5, Ad26, and ChAdY25 (ChAdOx1) were employed as vectors for SARS-CoV-2 vaccines. So far, more than 116 adenovirus genotypes have been identified, divided into 7 species (A-G). Most adenoviruses do not cause diseases or are mildly pathogenic, with only species B and...

Alternative Titles

Full title

The seroprevalence of adenoviruses since 2000 1

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_40035700

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_40035700

Other Identifiers

ISSN

2222-1751

E-ISSN

2222-1751

DOI

10.1080/22221751.2025.2475831

How to access this item